HOYA Begins Strategic Review of Medical Endoscopy Business

TOKYO, Jul 31 (Pulse News Wire) – HOYA Corporation (7741.T) announced today that it has initiated a strategic review of its medical endoscopy business, which includes domestic and overseas operations of PENTAX Medical. As part of portfolio optimization efforts aimed at long-term growth and capital efficiency, the company is considering various options, including potential divestitures to third parties.

The review comes amid plans to complete the spin-off of the domestic portion of the medical endoscopy business into a wholly-owned subsidiary effective August 1, 2026. However, no decisions have yet been made regarding the specific strategy, execution timeline, methods, or conditions for the international division.

Regarding future outlook, HOYA stated that the impact on its performance remains undetermined at this stage. The company committed to providing timely updates should significant developments arise during the ongoing evaluation process.